Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 923

1.

Relationship between socioeconomic and nutritional status in the Serbian adult population: a cross-sectional study.

Rakić JG, Maksimović M, Janković J, Vlajinac H, Marinković J.

Sao Paulo Med J. 2018 Aug 13. pii: S1516-31802018005012103. doi: 10.1590/1516-3180.2018.0038170418. [Epub ahead of print]

2.

Assessment of hypertension chronic care model: Pacic application in Bosnia and Herzegovina.

Pilipovic-Broceta N, Vasiljevic N, Marinkovic J, Todorovic N, Jankovic J, Ostric I, Kalimanovska-Ostric D, Racic M.

PLoS One. 2018 Aug 14;13(8):e0202250. doi: 10.1371/journal.pone.0202250. eCollection 2018.

3.

Essential Tremor.

Jankovic J.

N Engl J Med. 2018 Aug 9;379(6):595. doi: 10.1056/NEJMc1807690. No abstract available.

PMID:
30091352
4.

Parkinson's disease tremors and serotonin.

Jankovic J.

Brain. 2018 Mar 1;141(3):624-626. doi: 10.1093/brain/awx361. No abstract available.

PMID:
30063797
5.

Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma.

Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM; Undiagnosed Diseases Network, Dhar SU.

Neurol Genet. 2018 Jul 20;4(4):e248. doi: 10.1212/NXG.0000000000000248. eCollection 2018 Aug. No abstract available.

6.

Botulinum Toxin for the Treatment of Hand Tremor.

Niemann N, Jankovic J.

Toxins (Basel). 2018 Jul 19;10(7). pii: E299. doi: 10.3390/toxins10070299.

7.

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study.

Jankovic J, Truong D, Patel AT, Brashear A, Evatt M, Rubio RG, Oh CK, Snyder D, Shears G, Comella C.

Mov Disord Clin Pract. 2018 Apr 26;5(3):273-282. doi: 10.1002/mdc3.12613. eCollection 2018 May-Jun.

8.

Pattern of Response to Bronchial Challenge with Histamine in Patients with Non-Atopic Cough-Variant and Classic Asthma.

Zugic V, Mujovic N, Hromis S, Jankovic J, Drvenica M, Perovic A, Kopitovic I, Ilic A, Nikolic D.

J Clin Med. 2018 Jul 12;7(7). pii: E174. doi: 10.3390/jcm7070174.

9.

Deutetrabenazine for the treatment of Huntington's chorea.

Bashir H, Jankovic J.

Expert Rev Neurother. 2018 Jul 17:1-7. doi: 10.1080/14737175.2018.1500178. [Epub ahead of print]

PMID:
29996061
10.

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.

Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG.

JAMA Neurol. 2018 Jun 18. doi: 10.1001/jamaneurol.2018.1487. [Epub ahead of print]

PMID:
29913017
11.

Consensus for the measurement of the camptocormia angle in the standing patient.

Margraf NG, Wolke R, Granert O, Berardelli A, Bloem BR, Djaldetti R, Espay AJ, Fasano A, Furusawa Y, Giladi N, Hallett M, Jankovic J, Murata M, Tinazzi M, Volkmann J, Berg D, Deuschl G.

Parkinsonism Relat Disord. 2018 Jul;52:1-5. doi: 10.1016/j.parkreldis.2018.06.013. Epub 2018 Jun 8.

PMID:
29907329
12.

Preferred sampler inlet configurations for collection of aerosolized nano-scale materials.

Jankovic J, Zontek TL, Moore M, Ogle BR, Hollenbeck S.

Int J Occup Environ Health. 2018 Jun 14:1-6. doi: 10.1080/10773525.2018.1484995. [Epub ahead of print]

PMID:
29902943
13.

Semisolid self-microemulsifying drug delivery systems (SMEDDSs): Effects on pharmacokinetics of acyclovir in rats.

Djekic L, Janković J, Rašković A, Primorac M.

Eur J Pharm Sci. 2018 Jun 6;121:287-292. doi: 10.1016/j.ejps.2018.06.005. [Epub ahead of print]

PMID:
29883728
14.

Predictors of self-medication in Serbian adult population: cross-sectional study.

Tripković K, Nešković A, Janković J, Odalović M.

Int J Clin Pharm. 2018 Jun;40(3):627-634. doi: 10.1007/s11096-018-0624-x. Epub 2018 Mar 30.

PMID:
29603073
15.

Patterns of Health Care Utilization for Noncommunicable Diseases in a Transitional European Country: Results From the National Health Survey.

Janković J, Šiljak S, Marinković J, Kovač B, Janković S.

Int J Health Serv. 2018 Jan 1:20731418762717. doi: 10.1177/0020731418762717. [Epub ahead of print]

PMID:
29598810
16.

Cervical dystonia and substance abuse.

Mahajan A, Jankovic J, Marsh L, Patel A, Jinnah HA, Comella C, Barbano R, Perlmutter J, Patel N; members of the Dystonia Coalition.

J Neurol. 2018 Apr;265(4):970-975. doi: 10.1007/s00415-018-8840-9. Epub 2018 Mar 22.

PMID:
29569175
17.
18.

Tardive syndromes.

Savitt D, Jankovic J.

J Neurol Sci. 2018 Jun 15;389:35-42. doi: 10.1016/j.jns.2018.02.005. Epub 2018 Feb 5. Review.

PMID:
29506749
19.
20.

Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.

Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR, Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan I; ENGENE-PSP Study.

Mov Disord. 2018 Mar;33(3):468-472. doi: 10.1002/mds.27336. Epub 2018 Feb 20.

PMID:
29460982
21.

The nosology of tardive syndromes.

Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA.

J Neurol Sci. 2018 Jun 15;389:10-16. doi: 10.1016/j.jns.2018.02.008. Epub 2018 Feb 6.

PMID:
29433810
22.

Autoimmune and paraneoplastic movement disorders: An update.

Baizabal-Carvallo JF, Jankovic J.

J Neurol Sci. 2018 Feb 15;385:175-184. doi: 10.1016/j.jns.2017.12.035. Epub 2017 Dec 30. Review.

PMID:
29406902
23.

Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.

Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J.

Neurology. 2018 Feb 13;90(7):e559-e564. doi: 10.1212/WNL.0000000000004951. Epub 2018 Jan 17.

PMID:
29343468
24.

Leg stereotypy syndrome: phenomenology and prevalence.

Lotia M, York MK, Strutt AM, Jankovic J.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):692-695. doi: 10.1136/jnnp-2017-317057. Epub 2018 Jan 13.

PMID:
29332008
25.

Association between non-communicable disease multimorbidity and health care utilization in a middle-income country: population-based study.

Jankovic J, Mirkovic M, Jovic-Vranes A, Santric-Milicevic M, Terzic-Supic Z.

Public Health. 2018 Feb;155:35-42. doi: 10.1016/j.puhe.2017.11.014. Epub 2018 Jan 4.

PMID:
29306621
26.

The genetics of Parkinson disease.

Deng H, Wang P, Jankovic J.

Ageing Res Rev. 2018 Mar;42:72-85. doi: 10.1016/j.arr.2017.12.007. Epub 2017 Dec 26. Review.

PMID:
29288112
27.

Immunologic treatment of Parkinson's disease.

Jankovic J.

Immunotherapy. 2018 Feb;10(2):81-84. doi: 10.2217/imt-2017-0146. No abstract available.

PMID:
29260621
28.

Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

Robak LA, Jansen IE, van Rooij J, Uitterlinden AG, Kraaij R, Jankovic J; International Parkinson’s Disease Genomics Consortium (IPDGC), Heutink P, Shulman JM.

Brain. 2017 Dec 1;140(12):3191-3203. doi: 10.1093/brain/awx285.

PMID:
29140481
29.

Treatment options for chorea.

Bashir H, Jankovic J.

Expert Rev Neurother. 2018 Jan;18(1):51-63. doi: 10.1080/14737175.2018.1403899. Epub 2017 Nov 15.

PMID:
29120264
30.

Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.

Stojisavljević D, Janković J, Erić M, Marinković J, Janković S.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):568-574. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.046. Epub 2017 Oct 31.

PMID:
29097061
31.

Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease?

Jankovic J.

Nat Rev Neurol. 2017 Nov;13(11):643-644. doi: 10.1038/nrneurol.2017.140. Epub 2017 Sep 29. No abstract available.

PMID:
28960185
32.

The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.

Oshima M, Deitiker P, Jankovic J, Atassi MZ.

Immunol Invest. 2018 Jan;47(1):18-39. doi: 10.1080/08820139.2017.1368544. Epub 2017 Sep 11.

PMID:
28891721
33.

An update on new and unique uses of botulinum toxin in movement disorders.

Jankovic J.

Toxicon. 2018 Jun 1;147:84-88. doi: 10.1016/j.toxicon.2017.09.003. Epub 2017 Sep 6.

PMID:
28888928
34.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

PMID:
28887905
35.

Treatable inherited rare movement disorders.

Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodríguez-Violante M, Schöls L, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM; International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders.

Mov Disord. 2018 Jan;33(1):21-35. doi: 10.1002/mds.27140. Epub 2017 Sep 1. Review.

PMID:
28861905
36.

Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule.

Deitiker P, Oshima M, Jankovic J, Atassi MZ.

Immunol Lett. 2017 Oct;190:257-264. doi: 10.1016/j.imlet.2017.07.016. Epub 2017 Aug 16.

PMID:
28823519
37.

Statin-related musculoskeletal pain in Parkinson's disease.

Jankovic J.

Pain. 2017 Sep;158(9):1840. doi: 10.1097/j.pain.0000000000000969. No abstract available.

PMID:
28816887
38.

Anosmia and Ageusia in Parkinson's Disease.

Tarakad A, Jankovic J.

Int Rev Neurobiol. 2017;133:541-556. doi: 10.1016/bs.irn.2017.05.028. Epub 2017 Jun 27. Review.

PMID:
28802932
39.

Progress toward an integrated understanding of Parkinson's disease.

Rousseaux MWC, Shulman JM, Jankovic J.

F1000Res. 2017 Jul 12;6:1121. doi: 10.12688/f1000research.11820.1. eCollection 2017. Review.

40.

Inequalities in the utilization of health care services in a transition European country: results from the national population health survey.

Janković J, Šiljak S, Erić M, Marinković J, Janković S.

Int J Public Health. 2018 Mar;63(2):261-272. doi: 10.1007/s00038-017-1009-y. Epub 2017 Jul 14.

PMID:
28710507
41.

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM; Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators.

JAMA Neurol. 2017 Aug 1;74(8):977-982. doi: 10.1001/jamaneurol.2017.1352.

42.

An Approach to Determine the Prevalence of Poor Mental Health among Urban and Rural Population in Serbia Using Propensity Score Matching.

Šantrić-Milićević M, Rosić N, Babić U, Šupić-Terzić Z, Janković J, Todorović J, Trajković G.

Cent Eur J Public Health. 2017 Jun;25(2):106-112. doi: 10.21101/cejph.a4160.

43.

Functional (psychogenic) stereotypies.

Baizabal-Carvallo JF, Jankovic J.

J Neurol. 2017 Jul;264(7):1482-1487. doi: 10.1007/s00415-017-8551-7. Epub 2017 Jun 26.

PMID:
28653211
44.

Botulinum toxin: State of the art.

Jankovic J.

Mov Disord. 2017 Aug;32(8):1131-1138. doi: 10.1002/mds.27072. Epub 2017 Jun 22. Review.

PMID:
28639368
45.

Development of semisolid self-microemulsifying drug delivery systems (SMEDDSs) filled in hard capsules for oral delivery of aciclovir.

Djekic L, Jankovic J, Čalija B, Primorac M.

Int J Pharm. 2017 Aug 7;528(1-2):372-380. doi: 10.1016/j.ijpharm.2017.06.028. Epub 2017 Jun 12.

PMID:
28619449
46.

Research Priorities in Limb and Task-Specific Dystonias.

Pirio Richardson S, Altenmüller E, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Prudente CN, Hallett M.

Front Neurol. 2017 May 3;8:170. doi: 10.3389/fneur.2017.00170. eCollection 2017. Review.

47.

ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.

Carecchio M, Mencacci NE, Iodice A, Pons R, Panteghini C, Zorzi G, Zibordi F, Bonakis A, Dinopoulos A, Jankovic J, Stefanis L, Bhatia KP, Monti V, R'Bibo L, Veneziano L, Garavaglia B, Fusco C, Wood N, Stamelou M, Nardocci N.

Parkinsonism Relat Disord. 2017 Aug;41:37-43. doi: 10.1016/j.parkreldis.2017.05.004. Epub 2017 May 10.

48.

Diagnosis and Management of Parkinson's Disease.

Tarakad A, Jankovic J.

Semin Neurol. 2017 Apr;37(2):118-126. doi: 10.1055/s-0037-1601888. Epub 2017 May 16. Review.

PMID:
28511252
49.

Psychiatric associations of adult-onset focal dystonia phenotypes.

Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Vidailhet M, Bonnet C, Ondo W, Malaty IA, Rodríguez R, McDonald WM, Marsh L, Zurowski M, Bäumer T, Brüggemann N.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):595-602. doi: 10.1136/jnnp-2016-315461. Epub 2017 Apr 24.

50.

Apraclonidine in the treatment of ptosis.

Wijemanne S, Vijayakumar D, Jankovic J.

J Neurol Sci. 2017 May 15;376:129-132. doi: 10.1016/j.jns.2017.03.025. Epub 2017 Mar 16.

PMID:
28431598

Supplemental Content

Loading ...
Support Center